Pricing Log in Create free account

Organon & Co. (OGN) vs Pfizer Inc. (PFE)

Organon & Co. and Pfizer Inc. are both Drug Manufacturers General companies. Pfizer Inc. is the larger, with a market value of $167.8B against $3.6B — 46.5× the size. Organon & Co. trades at the lower P/E: 17.4× against 38.9×. Pfizer Inc. grew revenue faster over the last twelve months: −0.21% against −2.45%. Pfizer Inc. has the higher net margin (6.80% vs 3.41%) and the higher return on invested capital (6.30% vs 6.11%). Both pay a dividend; Pfizer Inc. yields more (5.81% vs 0.58%). Across the 23 metrics below, Pfizer Inc. leads on 14 and Organon & Co. on 9.

Valuation

Metric OGN PFE Drug Manufacturers General median
P/E 17.42 38.92 24.54
P/S 0.59 2.65 3.39
P/B 3.59 1.97 5.00
Price to free cash flow 7.79 16.55 16.55
EV/EBITDA 7.83 10.79 13.82
EV/Sales 1.80 3.46 4.03
Earnings yield 5.74% 2.57% 2.98%
Free cash flow yield 12.84% 6.04% 4.46%

Profitability

Metric OGN PFE Drug Manufacturers General median
Gross margin 52.68% 73.18% 72.77%
Operating margin 13.45% 21.70% 18.77%
Net margin 3.41% 6.80% 8.27%
Free cash flow margin 7.57% 17.25% 17.18%
Return on equity 24.04% 4.97% 5.87%
Return on assets 1.57% 2.13% 2.57%
Return on invested capital 6.11% 6.30% 6.11%

Growth

Metric OGN PFE Drug Manufacturers General median
Revenue growth (TTM) (2.45%) (0.21%) 6.66%
EPS growth (last fiscal year) (78.38%) (3.55%) 21.81%
Revenue growth, 5-year CAGR (0.99%) 8.48% 4.75%
Net income growth, 5-year CAGR (38.70%) (3.23%) 0.00%

Health

Metric OGN PFE Drug Manufacturers General median
Debt to equity 8.50 0.74 0.63
Current ratio 1.95 1.27 1.32
Net debt to EBITDA 5.62 2.46 1.15

Dividend

Metric OGN PFE Drug Manufacturers General median
Dividend yield 0.58% 5.81% 2.33%
Payout ratio 0.10 2.26 0.59

Size

Metric OGN PFE Drug Manufacturers General median
Market cap 3.61b 167.80b 123.73b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack